Thermo Fisher Scientific, Inc.

Equities

TMO

US8835561023

Market Closed - Nyse Other stock markets 04:00:02 2026-02-13 pm EST			5-day change	1st Jan Change
504.82 ^USD	-0.98%		-7.00%	-12.88%

Feb. 11	Thermo Fisher Scientific Expands Real-World Data Interoperability and Linkage Through Strategic Collaboration with Datavant	CI
Feb. 11	Thermo Fisher Collaborates With Datavant to Link Real-World Data With Clinical Research	MT

Transcript : Thermo Fisher Scientific Inc. Presents at 44th Annual J.P. Morgan Healthcare Conference, Jan-13-2026 08

Published on 01/13/2026 at 12:35 pm EST - Modified on 01/13/2026 at 02:35 pm EST

S&P Capital IQ

Presenter Speech
Casey Woodring (Analysts)

All right. Great. Welcome to the JPMorgan Healthcare Conference, Everybody. My name is Casey Woodring from the Life Science Tools & Diagnostics team. Pleased

This article is reserved for subscribers

Unlock the article : SUBSCRIBE!

Already a customer? Log In

Latest news about Thermo Fisher Scientific, Inc.

Feb. 11	Thermo Fisher Scientific Expands Real-World Data Interoperability and Linkage Through Strategic Collaboration with Datavant	CI
Feb. 11	Thermo Fisher Collaborates With Datavant to Link Real-World Data With Clinical Research	MT
Feb. 10	Thermo Fisher Scientific Prices $3.8 Billion Senior Notes	MT
Feb. 10	Thermo Fisher Scientific Prices Offering of USD-Denominated Senior Notes	CI
Feb. 09	Thermo Fisher Scientific says prices $3.8 bln offering of USD-denominated senior notes	RE
Feb. 09	Thermo Fisher Scientific files pricing term sheet for $3.8 billion four part senior notes offering	RE
Feb. 09	Thermo Fisher Scientific Inc files for four-part senior notes offering size not disclosed	RE
Feb. 05	Microsoft-Backed OpenAI Launches Frontier Platform to Manage Enterprise AI Agents	MT
Feb. 05	IQVIA forecasts weak annual profit on higher interest expenses	RE
Feb. 05	IXICO plc Appoints Tanya Voloshen as Chief Commercial Officer	CI
Feb. 04	Biotech firm Bio-Techne beats quarterly estimates on strength in key unit	RE
Feb. 02	Revvity forecasts 2026 profit, revenue above estimates after blowout fourth quarter	RE
Jan. 30	UBS Adjusts Price Target on Thermo Fisher Scientific to $615 From $590, Maintains Neutral Rating	MT
Jan. 30	Raymond James Adjusts Price Target on Thermo Fisher Scientific to $670 From $630, Maintains Outperform Rating	MT
Jan. 30	Baird Adjusts Price Target on Thermo Fisher Scientific to $653 From $645, Maintains Outperform Rating	MT